Labcorp Holdings Gross Profit Growth & History (LH)
Labcorp Holdings's gross profit was $4.01B for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.01B | $388.1M | +10.71% |
| 2024 | 2024-12-31 | $3.62B | $259.5M | +7.71% |
| 2023 | 2023-12-31 | $3.36B | −$344.0M | −9.27% |
| 2022 | 2022-12-31 | $3.71B | −$1.28B | −25.71% |
| 2021 | 2021-12-31 | $4.99B | $39.6M | +0.80% |
| 2020 | 2020-12-31 | $4.95B | $1.70B | +52.28% |
| 2019 | 2019-12-31 | $3.25B | $76.1M | +2.40% |
| 2018 | 2018-12-31 | $3.18B | $84.6M | +2.74% |
| 2017 | 2017-12-31 | $3.09B | $237.8M | +8.33% |
| 2016 | 2016-12-31 | $2.85B | −$49.3M | −1.70% |
| 2015 | 2015-12-31 | $2.90B | $700.2M | +31.78% |
| 2014 | 2014-12-31 | $2.20B | −$20.1M | −0.90% |
| 2013 | 2013-12-31 | $2.22B | −$26.5M | −1.18% |
| 2012 | 2012-12-31 | $2.25B | −$25.0M | −1.10% |
| 2011 | 2011-12-31 | $2.27B | $176.9M | +8.43% |
| 2010 | 2010-12-31 | $2.10B | $126.9M | +6.44% |
| 2009 | 2009-12-31 | $1.97B | $97.1M | +5.18% |
| 2008 | 2008-12-31 | $1.87B | $182.6M | +10.80% |
| 2007 | 2007-12-31 | $1.69B | — | — |
Labcorp Holdings quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.11B | $65.8M | +6.29% |
| Q1 2026 | 2026-03-31 | $1.01B | $65.8M | +6.94% |
| Q4 2025 | 2025-12-31 | $993.2M | $96.9M | +10.81% |
| Q3 2025 | 2025-09-30 | $1.03B | $120.7M | +13.35% |
| Q2 2025 | 2025-06-30 | $1.05B | $119.8M | +12.93% |
| Q1 2025 | 2025-03-31 | $948.0M | $50.7M | +5.65% |
| Q4 2024 | 2024-12-31 | $896.3M | $74.9M | +9.12% |
| Q3 2024 | 2024-09-30 | $904.4M | $53.2M | +6.25% |
| Q2 2024 | 2024-06-30 | $926.4M | $84.2M | +10.00% |
| Q1 2024 | 2024-03-31 | $897.3M | $47.2M | +5.55% |
| Q4 2023 | 2023-12-31 | $821.4M | $174.1M | +26.90% |
| Q3 2023 | 2023-09-30 | $851.2M | −$35.0M | −3.95% |
| Q2 2023 | 2023-06-30 | $842.2M | −$100.3M | −10.64% |
| Q1 2023 | 2023-03-31 | $850.1M | −$382.8M | −31.05% |
| Q4 2022 | 2022-12-31 | $647.3M | −$95.8M | −12.89% |
| Q3 2022 | 2022-09-30 | $886.2M | −$499.3M | −36.04% |
| Q2 2022 | 2022-06-30 | $942.5M | −$322.3M | −25.48% |
| Q1 2022 | 2022-03-31 | $1.23B | −$366.1M | −22.90% |
| Q4 2021 | 2021-12-31 | $743.1M | −$1.16B | −60.99% |
| Q3 2021 | 2021-09-30 | $1.39B | −$173.9M | −11.15% |
| Q2 2021 | 2021-06-30 | $1.26B | $504.3M | +66.31% |
| Q1 2021 | 2021-03-31 | $1.60B | $871.0M | +119.64% |
| Q4 2020 | 2020-12-31 | $1.90B | $1.08B | +132.11% |
| Q3 2020 | 2020-09-30 | $1.56B | $742.1M | +90.80% |
| Q2 2020 | 2020-06-30 | $760.5M | −$64.3M | −7.80% |
| Q1 2020 | 2020-03-31 | $728.0M | −$61.7M | −7.81% |
| Q4 2019 | 2019-12-31 | $820.7M | $48.3M | +6.25% |
| Q3 2019 | 2019-09-30 | $817.3M | $27.4M | +3.47% |
| Q2 2019 | 2019-06-30 | $824.8M | −$10.3M | −1.23% |
| Q1 2019 | 2019-03-31 | $789.7M | $10.7M | +1.37% |
| Q4 2018 | 2018-12-31 | $772.4M | −$44.7M | −5.47% |
| Q3 2018 | 2018-09-30 | $789.9M | $5.7M | +0.73% |
| Q2 2018 | 2018-06-30 | $835.1M | $57.1M | +7.34% |
| Q1 2018 | 2018-03-31 | $779.0M | $66.5M | +9.33% |
| Q4 2017 | 2017-12-31 | $817.1M | $29.1M | +3.69% |
| Q3 2017 | 2017-09-30 | $784.2M | −$4.2M | −0.53% |
| Q2 2017 | 2017-06-30 | $778.0M | −$48.8M | −5.90% |
| Q1 2017 | 2017-03-31 | $712.5M | −$64.8M | −8.34% |
| Q4 2016 | 2016-12-31 | $788.0M | $47.3M | +6.39% |
| Q3 2016 | 2016-09-30 | $788.4M | $23.5M | +3.07% |
| Q2 2016 | 2016-06-30 | $826.8M | $54.2M | +7.02% |
| Q1 2016 | 2016-03-31 | $777.3M | $152.2M | +24.35% |
| Q4 2015 | 2015-12-31 | $740.7M | $194.2M | +35.54% |
| Q3 2015 | 2015-09-30 | $764.9M | $193.7M | +33.91% |
| Q2 2015 | 2015-06-30 | $772.6M | $204.0M | +35.88% |
| Q1 2015 | 2015-03-31 | $625.1M | −$1.58B | −71.63% |
| Q4 2014 | 2014-12-31 | $546.5M | $20.4M | +3.88% |
| Q3 2014 | 2014-09-30 | $571.2M | $23.6M | +4.31% |
| Q2 2014 | 2014-06-30 | $568.6M | −$8.7M | −1.51% |
| Q1 2014 | 2014-03-31 | $2.20B | $1.63B | +285.02% |
| Q4 2013 | 2013-12-31 | $526.1M | −$11.9M | −2.21% |
| Q3 2013 | 2013-09-30 | $547.6M | −$8.5M | −1.53% |
| Q2 2013 | 2013-06-30 | $577.3M | −$2.2M | −0.38% |
| Q1 2013 | 2013-03-31 | $572.2M | −$3.9M | −0.68% |
| Q4 2012 | 2012-12-31 | $538.0M | −$11.6M | −2.11% |
| Q3 2012 | 2012-09-30 | $556.1M | −$12.4M | −2.18% |
| Q2 2012 | 2012-06-30 | $579.5M | −$8.7M | −1.48% |
| Q1 2012 | 2012-03-31 | $576.1M | $7.7M | +1.35% |
| Q4 2011 | 2011-12-31 | $549.6M | $20.0M | +3.78% |
| Q3 2011 | 2011-09-30 | $568.5M | $40.8M | +7.73% |
| Q2 2011 | 2011-06-30 | $588.2M | $54.6M | +10.23% |
| Q1 2011 | 2011-03-31 | $568.4M | $61.5M | +12.13% |
| Q4 2010 | 2010-12-31 | $529.6M | $53.6M | +11.26% |
| Q3 2010 | 2010-09-30 | $527.7M | $29.6M | +5.94% |
| Q2 2010 | 2010-06-30 | $533.6M | $26.2M | +5.16% |
| Q1 2010 | 2010-03-31 | $506.9M | $17.5M | +3.58% |
| Q4 2009 | 2009-12-31 | $476.0M | — | — |
| Q3 2009 | 2009-09-30 | $498.1M | $36.5M | +7.91% |
| Q2 2009 | 2009-06-30 | $507.4M | $15.6M | +3.17% |
| Q1 2009 | 2009-03-31 | $489.4M | — | — |
| Q3 2008 | 2008-09-30 | $461.6M | — | — |
| Q2 2008 | 2008-06-30 | $491.8M | — | — |
Labcorp Holdings gross profit trends
Over the last five fiscal years, Labcorp Holdings's gross profit decreased from $4.95B to $4.01B, a change of −$940.3M. The latest reported quarter, Q2 2026, shows $1.11B.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...